BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28255564)

  • 1. Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.
    Wang S; Zhang C; Wang J; Yang C; Xu M; Rong R; Zhu T; Zhu D
    J Immunol Res; 2017; 2017():8746303. PubMed ID: 28255564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D; Catar R; Philippe A
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological function of the endothelial cell within the setting of organ transplantation.
    Taflin C; Charron D; Glotz D; Mooney N
    Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies.
    Guo X; Hu J; Luo W; Luo Q; Guo J; Tian F; Ming Y; Zou Y
    J Immunol Res; 2017; 2017():8679841. PubMed ID: 28265584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and histology of humoral rejection in kidney transplantation.
    González-Molina M; Ruiz-Esteban P; Caballero A; Burgos D; Cabello M; Leon M; Fuentes L; Hernandez D
    Nefrologia; 2016; 36(4):354-67. PubMed ID: 27267916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway.
    Qin Y; Sun B; Zhang F; Wang Y; Shen B; Liu Y; Guo Y; Fan Y; Qiu J
    Exp Cell Res; 2019 Feb; 375(2):20-27. PubMed ID: 30639059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of endothelial cells in allograft rejection].
    Regele H
    Pathologe; 2008 Nov; 29 Suppl 2():141-4. PubMed ID: 18820919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.
    Butler CL; Valenzuela NM; Thomas KA; Reed EF
    J Immunol Res; 2017; 2017():7903471. PubMed ID: 28373996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.
    Stegall MD; Gloor JM
    Curr Opin Organ Transplant; 2010 Feb; 15(1):8-10. PubMed ID: 19890210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.
    Sicard A; Chen CC; Morelon E; Thaunat O
    Curr Opin Organ Transplant; 2016 Aug; 21(4):368-74. PubMed ID: 27258579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
    Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells.
    Opgenoorth M; Wagner A; Passauer J; Hohenstein B; Hugo C
    Atheroscler Suppl; 2015 May; 18():67-73. PubMed ID: 25936307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
    Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.
    Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B
    Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.
    Valenzuela NM; Reed EF
    J Clin Invest; 2017 Jun; 127(7):2492-2504. PubMed ID: 28604384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic antibody-mediated rejection: review of literature.
    Hassan R; Gheith O
    Iran J Kidney Dis; 2014 Mar; 8(2):93-103. PubMed ID: 24685730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.